MaxCyte | DEF 14A: Definitive information statements
Apr 26 17:22 ET
MaxCyte | 4: Statement of changes in beneficial ownership of securities-Director Johnston John Joseph
Mar 28 16:36 ET
MaxCyte | SC 13G: Statement of acquisition of beneficial ownership by individuals-Integrated Core Strategies (US) LLC(5.5%),Millennium Management LLC(5.5%), etc.
Mar 25 16:40 ET
MaxCyte | 4: Statement of changes in beneficial ownership of securities-Officer Ross Thomas M.
Mar 19 18:23 ET
MaxCyte | 4: Statement of changes in beneficial ownership of securities-Officer Sandoval David I.
Mar 19 18:23 ET
MaxCyte | 4: Statement of changes in beneficial ownership of securities-Officer Swirsky Douglas J
Mar 19 18:22 ET
MaxCyte | 10-K: Annual report
Mar 12 17:04 ET
MaxCyte | 8-K: MaxCyte Reports Fourth Quarter and Full Year 2023 Financial Results and Reiterates 2024 Guidance
Mar 12 16:15 ET
MaxCyte | 8-K: Current report
Mar 5 16:21 ET
MaxCyte | 3: Initial statement of beneficial ownership of securities-Officer Sandoval David I.
Mar 4 17:45 ET
MaxCyte | 4: Statement of changes in beneficial ownership of securities-Director Johnston John Joseph
Feb 28 22:38 ET
MaxCyte | 144: Notice of proposed sale of securities pursuant to Rule 144
Feb 26 16:31 ET
MaxCyte | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Casdin Capital, LLC(0%),Casdin Partners Master Fund, L.P.(0%), etc.
Feb 14 16:28 ET
MaxCyte | SC 13G: Statement of acquisition of beneficial ownership by individuals-Cadian Capital Management, LP(5.5%),Cadian Capital Management GP, LLC(5.5%), etc.
Feb 14 12:28 ET
MaxCyte | SC 13G: Statement of acquisition of beneficial ownership by individuals-The Vanguard Group(5.09%)
Feb 13 22:44 ET
MaxCyte | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Integrated Core Strategies (US) LLC(4.8%),Millennium Management LLC(4.8%), etc.
Feb 1 16:29 ET
MaxCyte | 4: Statement of changes in beneficial ownership of securities-Director Johnston John Joseph
Jan 30 16:33 ET
MaxCyte | 8-K: Current report
Jan 26 16:50 ET
MaxCyte | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(8.0%)
Jan 26 11:59 ET
MaxCyte | 8-K: MaxCyte Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Financial Results
Jan 8 00:00 ET
No Data
No Data